Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Naoko Kakisu"'
Autor:
Kaori Hisanaga, Kazutoshi Isobe, Kazuma Kishi, Takahisa Hirose, Naoko Kakisu, Fukumi Yoshikawa, Genki Sato, Hiroshi Uchino, Masahiko Miyagi, Sakae Homma
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Kaori Hisanaga,1 Hiroshi Uchino,1 Naoko Kakisu,1 Masahiko Miyagi,1 Fukumi Yoshikawa,1 Genki Sato,1 Kazutoshi Isobe,2 Kazuma Kishi,2 Sakae Homma,3 Takahisa Hirose1 1Division of Diabetes, Metabolism and Endocrinology, Department of Medicine, Toho Unive
Autor:
Kaori Hisanaga, Hiroshi Uchino, Naoko Kakisu, Masahiko Miyagi, Fukumi Yoshikawa, Genki Sato, Kazutoshi Isobe, Kazuma Kishi, Sakae Homma, Takahisa Hirose
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 14:3109-3110
Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773—781. Page 775, left column, third paragraph, line 4, the text “(p
Autor:
Kaori Hisanaga, hiroshi uchino, Naoko Kakisu, Masahiko Miyagi, Fukumi Yoshikawa, Genki Sato, Kazutoshi Isobe, Kazuma Kishi, Sakae Homma, Takahisa Hirose
Introduction: Although immune checkpoint inhibitors (ICIs) are promising in the treatment of advanced cancer, they may lead to immune-related adverse events (irAEs), which can affect endocrine organ systems. However, development of the irAEs was asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a874ec54032d5bf7f778c99a4edf6d5
https://doi.org/10.21203/rs.3.rs-49035/v1
https://doi.org/10.21203/rs.3.rs-49035/v1